![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Department of Biochemistry, College of Agricultural and Life Sciences, University of Wisconsin-Madison, Madison, WI 53706
3To whom correspondence should be addressed.
The active form of vitamin D (1,25-dihydroxycholecalciferol) is a potent immune system regulator. Treating mice with 1,25-dihydroxycholecalciferol and feeding them diets high in calcium can completely suppress the induction of experimental autoimmune diseases such as experimental autoimmune encephalomyelitis (EAE). Experiments described here were carried out on mice in which development of EAE was induced. Mice were fed diets containing various amounts of calcium and 1,25-dihydroxychole-calciferol. Variables measured were as follows: 1) incidence and severity of EAE; 2) serum calcium concentrations; 3) body weight; 4) total number of cells in the lymph nodes; and 5) interleukin-4 (IL-4) and transforming growth factor-ß1 (TGF-ß1) mRNA levels. When calcium was removed from the diet, the incidence of EAE was reduced 20% in both males and females. Further, the lower the dietary level of calcium, the higher was the dose of 1,25-dihydroxycholecalciferol required to prevent the symptoms. Thus, 1,25-dihydroxycholecalciferol was found most effective in mice fed a diet adequate or high in calcium. 1,25-Dihydroxycholecalciferol treatment of mice fed high dietary calcium resulted in a decreased number of lymphocytes in the lymph nodes and increased IL-4 and TGF-ß1 mRNA levels. When calcium was omitted from the diet, 1,25-dihydroxycholecalciferol supplementation increased TGF-ß1 mRNA. Increased IL-4 mRNA and decreased lymphocytes in the lymph nodes in response to 1,25-dihydroxycholecalciferol occurred only when dietary calcium was adequate or high. Our results suggest that dietary calcium and 1,25-dihydroxycholecalciferol are both involved in the prevention of symptomatic EAE.
KEY WORDS: • calcium • vitamin D • experimental autoimmune encephalomyelitis • multiple sclerosis • mice
This article has been cited by other articles:
|
|
 |
|
  K. M. Spach, F. E. Nashold, B. N. Dittel, and C. E. Hayes IL-10 Signaling Is Essential for 1,25-Dihydroxyvitamin D3-Mediated Inhibition of Experimental Autoimmune Encephalomyelitis J. Immunol., November 1, 2006; 177(9): 6030 - 6037. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Spach and C. E. Hayes Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice J. Immunol., September 15, 2005; 175(6): 4119 - 4126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakagawa, Y. Sasaki, S. Kato, N. Kubodera, and T. Okano 22-Oxa-1{alpha},25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer Carcinogenesis, June 1, 2005; 26(6): 1044 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Healy, J. L. Vanhooke, J. M. Prahl, and H. F. DeLuca Parathyroid hormone decreases renal vitamin D receptor expression in vivo PNAS, March 29, 2005; 102(13): 4724 - 4728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T Cantorna, Y. Zhu, M. Froicu, and A. Wittke Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1717S - 1720S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Spach, L. B. Pedersen, F. E. Nashold, T. Kayo, B. S. Yandell, T. A. Prolla, and C. E. Hayes Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis Physiol Genomics, July 8, 2004; 18(2): 141 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Dong, T. Craig, N. Xing, L. A. Bachman, C. V. Paya, F. Weih, D. J. McKean, R. Kumar, and M. D. Griffin Direct Transcriptional Regulation of RelB by 1{alpha},25-Dihydroxyvitamin D3 and Its Analogs: PHYSIOLOGIC AND THERAPEUTIC IMPLICATIONS FOR DENDRITIC CELL FUNCTION J. Biol. Chem., December 5, 2003; 278(49): 49378 - 49385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Froicu, V. Weaver, T. A. Wynn, M. A. McDowell, J. E. Welsh, and M. T. Cantorna A Crucial Role for the Vitamin D Receptor in Experimental Inflammatory Bowel Diseases Mol. Endocrinol., December 1, 2003; 17(12): 2386 - 2392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Grant, J. A. Wiesinger, J. L. Beard, and M. T. Cantorna Iron-Deficient Mice Fail to Develop Autoimmune Encephalomyelitis J. Nutr., August 1, 2003; 133(8): 2635 - 2638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Meehan and H. F. DeLuca CD8+ T cells are not necessary for 1alpha ,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice PNAS, April 16, 2002; 99(8): 5557 - 5560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. F. DELUCA and M. T. CANTORNA Vitamin D: its role and uses in immunology FASEB J, December 1, 2001; 15(14): 2579 - 2585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Cantorna, C. Munsick, C. Bemiss, and B. D. Mahon 1,25-Dihydroxycholecalciferol Prevents and Ameliorates Symptoms of Experimental Murine Inflammatory Bowel Disease J. Nutr., November 1, 2000; 130(11): 2648 - 2652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Meehan and H. F. DeLuca CD8+ T cells are not necessary for 1alpha ,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice PNAS, April 16, 2002; 99(8): 5557 - 5560. [Abstract] [Full Text] [PDF]
|
|
